GENEVA, March 11 -- ENGRAIL THERAPEUTICS, INC. (12750 High Bluff Drive, Suite 190San Diego, California 92130) filed a patent application (PCT/US2025/043569) for "GABA A RECEPTOR MODULATOR ANTISEIZURE TREATMENTS" on Aug 26, 2025. With publication no. WO/2026/050276, the details related to the patent application was published on Mar 05, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): VADODARIA, Krishna (c/o Engrail Therapeutics, Inc.12750 High Bluff Drive, Suite 190San Diego, California 92130), VANOVER, Kimberly (c/o Engrail Therapeutics, Inc.12750 High Bluff Drive, Suite 190San Diego, Califor...